A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth. (2013)

First Author: Kaliszczak M
Attributed to:  Molecular Therapy funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2012.576

PubMed Identifier: 23322205

Publication URI: http://europepmc.org/abstract/MED/23322205

Type: Journal Article/Review

Volume: 108

Parent Publication: British journal of cancer

Issue: 2

ISSN: 0007-0920